Nevertheless, despite BRAFV600E induces both DNA damage and p21CIP1 activation in vitro [51, 55] as well as in senescent lung adenomas [17], we found no differences in p21CIP1 levels either in liver or spleen upon BRAFV600E expression. Here, CDKN1A is linked to lung adenoma.